CN103074334A - 检测cho细胞dna的方法 - Google Patents
检测cho细胞dna的方法 Download PDFInfo
- Publication number
- CN103074334A CN103074334A CN2012104759801A CN201210475980A CN103074334A CN 103074334 A CN103074334 A CN 103074334A CN 2012104759801 A CN2012104759801 A CN 2012104759801A CN 201210475980 A CN201210475980 A CN 201210475980A CN 103074334 A CN103074334 A CN 103074334A
- Authority
- CN
- China
- Prior art keywords
- primer
- seq
- hamster ovary
- chinese hamster
- genomic dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 39
- 210000004978 chinese hamster ovary cell Anatomy 0.000 title abstract description 5
- 238000001514 detection method Methods 0.000 claims abstract description 68
- 230000035945 sensitivity Effects 0.000 claims abstract description 14
- 210000001672 ovary Anatomy 0.000 claims description 75
- 241000699802 Cricetulus griseus Species 0.000 claims description 74
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 claims description 73
- 239000000523 sample Substances 0.000 claims description 39
- 238000012360 testing method Methods 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 230000003321 amplification Effects 0.000 claims description 16
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 16
- 108091033319 polynucleotide Proteins 0.000 claims description 13
- 102000040430 polynucleotide Human genes 0.000 claims description 13
- 239000002157 polynucleotide Substances 0.000 claims description 13
- 238000007403 mPCR Methods 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 230000009870 specific binding Effects 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 abstract description 22
- 241000588724 Escherichia coli Species 0.000 abstract description 9
- 241000699800 Cricetinae Species 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 241000699670 Mus sp. Species 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 106
- 239000000047 product Substances 0.000 description 20
- 239000012925 reference material Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 14
- 230000008569 process Effects 0.000 description 9
- 239000012634 fragment Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 101150040312 cho gene Proteins 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 229940124872 Hepatitis B virus vaccine Drugs 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000029610 recognition of host Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (17)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210475980.1A CN103074334B (zh) | 2012-11-20 | 2012-11-20 | 检测cho细胞dna的方法 |
PCT/CN2013/087448 WO2014079350A1 (zh) | 2012-11-20 | 2013-11-19 | 检测cho细胞dna的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210475980.1A CN103074334B (zh) | 2012-11-20 | 2012-11-20 | 检测cho细胞dna的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103074334A true CN103074334A (zh) | 2013-05-01 |
CN103074334B CN103074334B (zh) | 2015-05-13 |
Family
ID=48151029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210475980.1A Active CN103074334B (zh) | 2012-11-20 | 2012-11-20 | 检测cho细胞dna的方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103074334B (zh) |
WO (1) | WO2014079350A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014079350A1 (zh) * | 2012-11-20 | 2014-05-30 | 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 | 检测cho细胞dna的方法 |
CN104762405A (zh) * | 2015-04-22 | 2015-07-08 | 北京嘉宝仁和医疗科技有限公司 | 一种单细胞基因组扩增后扩增产物质量鉴定的方法和试剂盒 |
CN105441438A (zh) * | 2015-12-01 | 2016-03-30 | 北京科兴中维生物技术有限公司 | 检测人二倍体细胞dna的试剂盒及其应用 |
CN105803050A (zh) * | 2014-12-29 | 2016-07-27 | 上海伯安生物科技有限公司 | 检测cho细胞dna的引物及方法 |
CN105861641A (zh) * | 2015-01-23 | 2016-08-17 | 珠海市丽珠单抗生物技术有限公司 | 一种用于检测cho细胞dna残留的引物、试剂盒及检测方法 |
CN109837345A (zh) * | 2017-11-24 | 2019-06-04 | 中国食品药品检定研究院 | 检测小鼠细胞残留dna的引物及方法 |
CN112301028A (zh) * | 2020-10-27 | 2021-02-02 | 武汉珈创生物技术股份有限公司 | 一种用于鉴定cho细胞的scar标记及其构建方法和应用 |
CN115976232A (zh) * | 2023-01-05 | 2023-04-18 | 鲲鹏基因(北京)科技有限责任公司 | 利用分子信标检测cho核酸残留的方法及引物和试剂盒 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114634975B (zh) * | 2022-05-18 | 2022-08-12 | 北京万泰生物药业股份有限公司 | 一种检测细胞dna含量的方法及其试剂盒 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154503A (zh) * | 2011-04-20 | 2011-08-17 | 上海复宏汉霖生物技术有限公司 | 探针法检测cho细胞dna含量的方法 |
CN102181530A (zh) * | 2011-03-18 | 2011-09-14 | 上海复宏汉霖生物技术有限公司 | 用于cho细胞dna残留检测的试剂盒及其使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103074334B (zh) * | 2012-11-20 | 2015-05-13 | 上海凯锐斯生物科技有限公司 | 检测cho细胞dna的方法 |
-
2012
- 2012-11-20 CN CN201210475980.1A patent/CN103074334B/zh active Active
-
2013
- 2013-11-19 WO PCT/CN2013/087448 patent/WO2014079350A1/zh active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102181530A (zh) * | 2011-03-18 | 2011-09-14 | 上海复宏汉霖生物技术有限公司 | 用于cho细胞dna残留检测的试剂盒及其使用方法 |
CN102154503A (zh) * | 2011-04-20 | 2011-08-17 | 上海复宏汉霖生物技术有限公司 | 探针法检测cho细胞dna含量的方法 |
Non-Patent Citations (2)
Title |
---|
《GeneBank》 20070106 Lamnert,B.G.et al. GeneBank:EF540878.1 , * |
LAMNERT,B.G.ET AL.: "GeneBank:EF540878.1", 《GENEBANK》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014079350A1 (zh) * | 2012-11-20 | 2014-05-30 | 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 | 检测cho细胞dna的方法 |
CN105803050A (zh) * | 2014-12-29 | 2016-07-27 | 上海伯安生物科技有限公司 | 检测cho细胞dna的引物及方法 |
CN105803050B (zh) * | 2014-12-29 | 2020-10-16 | 湖州申科生物技术有限公司 | 检测cho细胞dna的引物及方法 |
CN105861641A (zh) * | 2015-01-23 | 2016-08-17 | 珠海市丽珠单抗生物技术有限公司 | 一种用于检测cho细胞dna残留的引物、试剂盒及检测方法 |
CN104762405A (zh) * | 2015-04-22 | 2015-07-08 | 北京嘉宝仁和医疗科技有限公司 | 一种单细胞基因组扩增后扩增产物质量鉴定的方法和试剂盒 |
CN105441438A (zh) * | 2015-12-01 | 2016-03-30 | 北京科兴中维生物技术有限公司 | 检测人二倍体细胞dna的试剂盒及其应用 |
CN109837345A (zh) * | 2017-11-24 | 2019-06-04 | 中国食品药品检定研究院 | 检测小鼠细胞残留dna的引物及方法 |
CN109837345B (zh) * | 2017-11-24 | 2022-08-02 | 中国食品药品检定研究院 | 检测小鼠细胞残留dna的引物及方法 |
CN112301028A (zh) * | 2020-10-27 | 2021-02-02 | 武汉珈创生物技术股份有限公司 | 一种用于鉴定cho细胞的scar标记及其构建方法和应用 |
CN112301028B (zh) * | 2020-10-27 | 2021-06-08 | 武汉珈创生物技术股份有限公司 | 一种用于鉴定cho细胞的scar标记及其构建方法和应用 |
CN115976232A (zh) * | 2023-01-05 | 2023-04-18 | 鲲鹏基因(北京)科技有限责任公司 | 利用分子信标检测cho核酸残留的方法及引物和试剂盒 |
CN115976232B (zh) * | 2023-01-05 | 2023-08-15 | 鲲鹏基因(北京)科技有限责任公司 | 利用分子信标检测cho核酸残留的方法及引物和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
WO2014079350A1 (zh) | 2014-05-30 |
CN103074334B (zh) | 2015-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103074334B (zh) | 检测cho细胞dna的方法 | |
CN106947838B (zh) | 非洲猪瘟病毒非结构基因实时荧光lamp检测引物组、试剂盒及检测方法 | |
CN113186313A (zh) | 基于RPA-LbCas12a-TTECDS体系的沙门氏菌检测引物组、方法与试剂盒 | |
CN113025726A (zh) | Lfd-rpa可视化快速检测日本血吸虫核酸的引物、探针、试剂盒及方法 | |
CN102676698A (zh) | Prv、pcv-2、ppv多重pcr检测试剂盒 | |
CN109837345A (zh) | 检测小鼠细胞残留dna的引物及方法 | |
CN110804652B (zh) | 一种快速检测dna的实时定量pcr的添加剂、试剂盒及反应方法 | |
CN102634605A (zh) | 检测鸡产蛋下降综合征病毒的方法及其试剂盒 | |
CN110592268A (zh) | 罗湖病毒(TiLV)的RAA恒温荧光检测方法及试剂 | |
CN104561383A (zh) | 流感病毒a型、b型联合检测引物、探针、试剂盒及应用 | |
CN105803050B (zh) | 检测cho细胞dna的引物及方法 | |
CN103397108A (zh) | 猪瘟兔化弱毒疫苗荧光定量rt-pcr检测试剂盒 | |
CN111549165A (zh) | 腐皮镰刀菌的rt-qpcr检测的引物、探针、试剂盒及方法 | |
CN110592274A (zh) | 大黄鱼虹彩病毒(lyciv)的raa恒温荧光检测方法及试剂 | |
CN106676163B (zh) | 检测毕赤酵母细胞dna的引物及方法 | |
CN102071264B (zh) | 禽流感病毒通用型套式荧光rt-pcr检测方法及检测试剂盒 | |
CN107988429B (zh) | 一种检测狂犬病毒的试剂及其应用 | |
CN110592270A (zh) | 锦鲤疱疹病毒(khv)的raa恒温荧光检测方法及试剂 | |
CN104894232A (zh) | 弗氏柠檬酸杆菌荧光定量pcr诊断试剂盒 | |
CN102618658B (zh) | 转基因玉米tc1507品系特异定量pcr精准检测方法 | |
CN104178575B (zh) | 一种快速鉴别胎儿弯曲菌和性病亚种的方法和试剂盒 | |
CN113846182B (zh) | 一种快速可视化检测pcv3的试剂盒及其检测方法 | |
CN102424863B (zh) | 一种增强型荧光定量pcr方法 | |
CN102199599B (zh) | 一种转基因番茄特异性检测靶序列、质粒标准分子及其检测试剂盒 | |
CN107034311A (zh) | 快速检测鸭瘟病毒lamp试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Tao Inventor after: Sun Weijie Inventor after: Yang Zhixing Inventor after: Wu Wanxin Inventor after: Wen Ming Inventor after: Zhu Bingmei Inventor after: Yu Yan Inventor before: Sun Weijie Inventor before: Yang Zhixing Inventor before: Wu Wanxin Inventor before: Wen Ming |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN WEIJIE YANG ZHIXING WU WANXIN WEN MING TO: WANG TAO SUN WEIJIE YANG ZHIXING WU WANXIN WEN MING ZHU BINGMEI YU YAN |
|
ASS | Succession or assignment of patent right |
Owner name: KAIRUISI BIOTECHNOLOGY CO., LTD., SHANGHAI Free format text: FORMER OWNER: BEIJING COSCI MED-TECH CO., LTD. Effective date: 20150311 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 313000 HUZHOU, ZHEJIANG PROVINCE TO: 200040 JING'AN, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150311 Address after: 200040 -6, 580 Jiangning Road, Shanghai, Jingan District Applicant after: SHANGHAI CARES BIOTECH Co.,Ltd. Address before: 5, 313000 floor, Huzhou South Taihu science and technology innovation center, 1366 Hongfeng Road, Zhejiang, Huzhou Applicant before: HUZHOU R & D CENTER FOR NUTRITION AND HEALTH, SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCE |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180531 Address after: 313000 Room 502, R & D building, South Taihu science and technology center, 1366 Hongfeng Road, Huzhou, Zhejiang. Patentee after: HUZHOU SHENKE BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 200040 Jiangning Road, Jingan District, Shanghai, No. 580 -6 Patentee before: SHANGHAI CARES BIOTECH Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: 1007-1, Floor 10, Building 3, No. 1366, Hongfeng Road, Huzhou City, Zhejiang Province, 313001 (independent application) Patentee after: Huzhou Shenke Biotechnology Co.,Ltd. Address before: 313000 Room 502, R & D building, South Taihu science and technology center, 1366 Hongfeng Road, Huzhou, Zhejiang. Patentee before: HUZHOU SHENKE BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address |